Ann: Cellmid Investor Presentation, page-25

We seem to be changing tack.
Previously the heading we were on involved the distribution and sales of Evolis mainly as an attempt to provide for clinical trials of a comprehensive midkine portfolio.

Although the end game is still the same it would seem by the addition of Fillerina and other soon to be announced product releases that there is a shift to a full beautycare scene.

I get the feeling that some of the salons involved with Evolis so far may be ideally placed for some development into full fledged beauty parlours as opposed to just hair dressing and treatment.

The hand of Dennis Eck would be invaluable if this were to happen
The main supply requirements could be handled by Evolis.

Weren't they looking for more warehouse space recently?
Seem to recall a relocation being looked at.